First Report of the Prevalence at Baseline and after 1-Year Follow-Up of Treatable Traits in Interstitial Lung Diseases

Different factors, not limited to the lung, influence the progression of ILDs. A “treatable trait” strategy was recently proposed for ILD patients as a precision model of care to improve outcomes. However, no data have been published so far on the prevalence of TTs in ILD. A prospective, observation...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Biomedicines Jg. 12; H. 5; S. 1047
Hauptverfasser:	Amati, Francesco, Stainer, Anna, Maruca, Giacomo, De Santis, Maria, Mangiameli, Giuseppe, Torrisi, Chiara, Bossi, Paola, Polelli, Veronica, Blasi, Francesco, Selmi, Carlo, Marulli, Giuseppe, Balzarini, Luca, Terracciano, Luigi Maria, Gatti, Roberto, Aliberti, Stefano
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Switzerland MDPI AG 01.05.2024
Schlagworte:	Airway management Asthma Cardiology Chronic obstructive pulmonary disease Clinical outcomes Comorbidity Connective tissue diseases Cough Development and progression Emphysema endotypes Genotype & phenotype interstitial lung diseases Kinases Lung diseases Medical prognosis Patients Pharmaceutical industry phenotypes Population studies Precision medicine Quality of life Respiratory diseases Respiratory failure Sarcoidosis treatable traits Treprostinil Germany endotypes treatable traits phenotypes interstitial lung diseases
ISSN:	2227-9059, 2227-9059
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!